tiprankstipranks
Corbus Pharmaceuticals (CRBP)
NASDAQ:CRBP
US Market

Corbus Pharmaceuticals (CRBP) Income Statement

Compare
2,354 Followers

Corbus Pharmaceuticals Income Statement

Last quarter (Q4 2024), Corbus Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Corbus Pharmaceuticals's net income was $-9.53M. See Corbus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 881.71K$ 3.94M
Gross Profit
$ 0.00$ -31.17M$ -1.49M$ -757.53K$ 3.84M
Operating Expenses
$ 48.72M$ 13.91M$ 34.84M$ 56.87M$ 126.75M
Depreciation and Amortization
$ 0.00$ 641.00K$ 1.49M$ 1.64M$ 1.69M
EBITDA
$ 0.00$ -44.44M$ -38.73M$ -54.97M$ -121.69M
Operating Income
$ 0.00$ -45.08M$ -39.84M$ -55.99M$ -122.81M
Other Income/Expenses
$ 0.00$ 473.99K$ -2.51M$ 10.35M$ 11.54M
Pretax Income
$ -40.21M$ -44.60M$ -42.35M$ -45.64M$ -111.27M
Net Income
$ -40.21M$ -44.60M$ -55.83M$ -45.55M$ -111.30M
Per Share Metrics
Basic EPS
$ -3.68$ -10.31$ -13.39$ -11.11$ -42.74
Diluted EPS
$ -3.68$ -10.31$ -13.39$ -11.11$ -42.74
Weighted Average Shares Outstanding
10.92M 4.33M 4.17M 4.10M 2.60M
Weighted Average Shares Outstanding (Diluted)
10.92M 4.33M 4.17M 4.10M 2.60M
Currency in USD

Corbus Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis